Target
Estrogen receptor
Ligand
BDBM50572835
Substrate
n/a
Meas. Tech.
ChEMBL_2118286 (CHEMBL4827352)
IC50
0.980000±n/a nM
Citation
 Liang, JZbieg, JRBlake, RAChang, JHDaly, SDiPasquale, AGFriedman, LSGelzleichter, TGill, MGiltnane, JMGoodacre, SGuan, JHartman, SJIngalla, ERKategaya, LKiefer, JRKleinheinz, TLabadie, SSLai, TLi, JLiao, JLiu, ZMody, VMcLean, NMetcalfe, CNannini, MAOeh, JO'Rourke, MGOrtwine, DFRan, YRay, NCRoussel, FSambrone, ASampath, DSchutt, LKVinogradova, MWai, JWang, TWertz, IEWhite, JRYeap, SKYoung, AZhang, BZheng, XZhou, WZhong, YWang, X GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer. J Med Chem 64:11841-11856 (2021) [PubMed]  Article 
Target
Name:
Estrogen receptor
Synonyms:
ER | ER-alpha | ESR | ESR1 | ESR1_HUMAN | Estradiol receptor | Estrogen receptor | Estrogen receptor (ER alpha) | Estrogen receptor (ER-alpha) | Estrogen receptor alpha (ER alpha) | Estrogen receptor alpha (ER) | NR3A1 | Nuclear receptor subfamily 3 group A member 1
Type:
Protein
Mol. Mass.:
66230.44
Organism:
Human
Description:
P03372
Residue:
595
Sequence:
MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPFLQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV
  
Inhibitor
Name:
BDBM50572835
Synonyms:
CHEMBL4865515
Type:
Small organic molecule
Emp. Form.:
C27H32F4N4O
Mol. Mass.:
504.5628
SMILES:
C[C@@H]1Cc2c([nH]c3ccccc23)[C@H](N1CC(F)(F)CO)c1ccc(NC2CN(CCCF)C2)cc1F |r|
Structure:
Search PDB for entries with ligand similarity: